How To Design Selective Ligands for Highly Conserved Binding Sites

webinar

Tue, 23 Feb 2021, 16:00 CET (Berlin)

Dr. Christian Kersten, University of Mainz

How To Design Selective Ligands for Highly Conserved Binding Sites

One major goal of each drug design project is to obtain high affinity ligands for a certain target while maintaining selectivity over potential off-targets and thereby reducing side effects. That however proves to be challenging when facing a highly conserved binding site. Using the N-myristoyltransferase of Leishmania major and the human homologue as a model system, the molecular selectivity-determining features for different inhibitors were identified by computational and experimental methods. By understanding these features, novel selective inhibitors were identified and a guideline on the considerations to make when facing conserved binding sites is presented.

Current news

category
Software
New Platform: High-Performance Computing with HPSee
May 13, 2024 23:00 CEST
We are excited to announce the release of BioSolveIT’s third platform — HPSee! HPSee is your scalable workflow environment for high-performance computing and virtual screening. It was developed to facilitate and enable large-scale computations such as structure-based virtual screening in a sophisticated and efficient manner.   The initial version 1.0, named...
Read on
category
Software
'Midas' Update: SeeSAR 13.1 — Covalent Docking and External Docking Mode
May 13, 2024 23:00 CEST
SeeSAR 13.1 is here and it comes with a truckload of new features! The update to ‘Midas’ is not only able to synergize with the new BioSolveIT platform HPSee, but will convince with a plethora of quality-of-life improvements. Therefore it may not surprise, that we are especially proud of the...
Read on
category
Software
Preview on Chemical Space Docking
April 26, 2024 15:34 CEST
Yes, you read it right. Chemical Space Docking is on the horizon! The novel approach is the next level of structure-based virtual screening where billion-or even trillion-sized Chemical Space can be screened for the most promising drug candidates. A spotlight on the upcoming implementation of Chemical Space Docking illustrates the...
Read on